Aspira Women’s Health Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Aspira Women's Health Inc. reported Cash And Cash Equivalents At Carrying Value of $1.77 million for the year ending 2024.

  • Aspira Women's Health Inc. showed a decrease of -31.9% in Cash And Cash Equivalents At Carrying Value from 2023 to 2024.
  • This data is from Aspira Women's Health Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2025.
  • XBRL data for this metric is available from 2009 to 2024 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q2 2010: $28.58 million | Q3 2010: $25.29 million | Q1 2011: $40.23 million | Q2 2011: $36.29 million | Q3 2011: $27.23 million | Q1 2012: $19.85 million | Q2 2012: $18.29 million | Q3 2012: $16.33 million | Q1 2013: $5.83 million | Q2 2013: $16.39 million | Q3 2013: $14.60 million | Q1 2014: $25.99 million | Q2 2014: $22.19 million | Q3 2014: $16.76 million | Q1 2015: $17.24 million | Q2 2015: $10.88 million | Q3 2015: $23.97 million | Q1 2016: $13.07 million | Q2 2016: $11.06 million | Q3 2016: $8.08 million | Q1 2017: $7.90 million | Q2 2017: $6.03 million | Q3 2017: $7.75 million | Q1 2021: $59.37 million | Q2 2021: $52.99 million | Q3 2021: $44.87 million | Q1 2022: $26.86 million | Q2 2022: $20.48 million | Q3 2022: $20.55 million | Q1 2023: $7.54 million | Q2 2023: $4.25 million | Q3 2023: $5.10 million | Q1 2024: $3.41 million | Q2 2024: $962.0 thousand | Q3 2024: $2.13 million | Q4 2024: $1.77 million | Q1 2025: $3.31 million | Q2 2025: $1.55 million | Q3 2025: $3.81 million.
  • Over the full 14 years of available data (2009 to 2024), Aspira Women's Health Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 48.6%.
  • Historical annual values: Fiscal year 2024: $1.77 million | Fiscal year 2023: $2.60 million | Fiscal year 2022: $13.31 million | Fiscal year 2021: $37.18 million | Fiscal year 2020: $16.63 million | Fiscal year 2017: $5.54 million | Fiscal year 2016: $5.24 million | Fiscal year 2015: $18.64 million | Fiscal year 2014: $22.97 million | Fiscal year 2013: $29.50 million | Fiscal year 2012: $8.01 million | Fiscal year 2011: $22.48 million | Fiscal year 2010: $22.91 million | Fiscal year 2009: $3.44 million.
  • Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: